Non-Toxic Virucidal Macromolecules Show High Efficacy Against Influenza Virus Ex Vivo and In Vivo.

3’SLN 6’SLN Influenza antivirals virucidal

Journal

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 18 03 2020
revised: 07 09 2020
entrez: 8 2 2021
pubmed: 9 2 2021
medline: 9 2 2021
Statut: epublish

Résumé

Influenza is one of the most widespread viral infections worldwide and represents a major public health problem. The risk that one of the next pandemics is caused by an influenza strain is high. It is important to develop broad-spectrum influenza antivirals to be ready for any possible vaccine shortcomings. Anti-influenza drugs are available but they are far from ideal. Arguably, an ideal antiviral should target conserved viral domains and be virucidal, that is, irreversibly inhibit viral infectivity. Here, a new class of broad-spectrum anti-influenza macromolecules is described that meets these criteria and display exceedingly low toxicity. These compounds are based on a cyclodextrin core modified on its primary face with long hydrophobic linkers terminated either in 6'sialyl-

Identifiants

pubmed: 33552848
doi: 10.1002/advs.202001012
pii: ADVS2213
pmc: PMC7856883
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2001012

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201700041I
Pays : United States

Informations de copyright

© 2020 The Authors. Advanced Science published by Wiley‐VCH GmbH.

Déclaration de conflit d'intérêts

O.K., V.C., C.T., and F.S. are inventors on patent number EP18192559.5. All the other authors declare no conflict of interest.

Références

Science. 2006 Apr 21;312(5772):389-91
pubmed: 16627735
Immunity. 2017 Apr 18;46(4):587-595
pubmed: 28423338
PLoS Pathog. 2016 Feb 04;12(2):e1005409
pubmed: 26845438
MAbs. 2016 Jul;8(5):991-7
pubmed: 27031797
Nat Biotechnol. 2017 Jul;35(7):667-671
pubmed: 28604661
J Virol. 2014 Feb;88(3):1447-60
pubmed: 24198411
Science. 2019 Mar 8;363(6431):
pubmed: 30846569
J Allergy Clin Immunol. 2018 Jun;141(6):2074-2084
pubmed: 28797733
Nat Microbiol. 2020 Jan;5(1):27-33
pubmed: 31768027
Eur J Pediatr. 2017 Oct;176(10):1425-1428
pubmed: 28852864
Sci Adv. 2020 Jan 29;6(5):eaax9318
pubmed: 32064341
Nat Med. 2004 Dec;10(12 Suppl):S82-7
pubmed: 15577936
Virol J. 2013 May 15;10:149
pubmed: 23672278
Biomaterials. 2017 Sep;138:22-34
pubmed: 28550754
Clin Infect Dis. 2010 Dec 15;51(12):1362-9
pubmed: 21070141
Nat Commun. 2017 Jan 19;8:14234
pubmed: 28102191
J Infect Dis. 1998 Jul;178(1):53-60
pubmed: 9652423
Biomaterials. 2016 Feb;78:74-85
pubmed: 26686050
Vaccine. 2018 Jun 22;36(27):3960-3966
pubmed: 29801998
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17667-71
pubmed: 17101983
Nat Struct Mol Biol. 2018 Feb;25(2):115-121
pubmed: 29396418
Lancet. 2006 Apr 29;367(9520):1405-11
pubmed: 16650650
Cell. 2016 Jul 28;166(3):596-608
pubmed: 27453466
Antimicrob Agents Chemother. 2015 Feb;59(2):1061-9
pubmed: 25451059
Nat Nanotechnol. 2017 Jan;12(1):48-54
pubmed: 27775724
Nat Rev Microbiol. 2014 Nov;12(11):739-49
pubmed: 25263223
Nat Rev Microbiol. 2019 Jan;17(2):67-81
pubmed: 30487536
Influenza Other Respir Viruses. 2017 May;11(3):240-246
pubmed: 28146320
Antimicrob Agents Chemother. 2010 Jun;54(6):2517-24
pubmed: 20350949
Science. 2011 Aug 12;333(6044):843-50
pubmed: 21737702
PLoS One. 2013 Oct 23;8(10):e76363
pubmed: 24194835
Annu Rev Pathol. 2008;3:499-522
pubmed: 18039138
Eur J Med Chem. 2019 Mar 15;166:328-338
pubmed: 30731401
Bioconjug Chem. 1999 Mar-Apr;10(2):271-8
pubmed: 10077477
Nat Mater. 2018 Feb;17(2):195-203
pubmed: 29251725
Vaccine. 2007 Sep 28;25(39-40):6852-62
pubmed: 17719149
Clin Infect Dis. 2003 Oct 15;37(8):1094-101
pubmed: 14523774
J Antimicrob Chemother. 2010 Feb;65(2):275-84
pubmed: 19942616
Chembiochem. 2011 Apr 11;12(6):887-95
pubmed: 21384484
Influenza Other Respir Viruses. 2014 Jul;8(4):406-13
pubmed: 24750586
Annu Rev Med. 2013;64:189-202
pubmed: 23327522
Cell. 2019 May 16;177(5):1136-1152.e18
pubmed: 31100268
Angew Chem Int Ed Engl. 2017 May 15;56(21):5931-5936
pubmed: 28444849
Emerg Infect Dis. 2015 Aug;21(8):1372-8
pubmed: 26196098

Auteurs

Ozgun Kocabiyik (O)

Insitute of Materials École Polytechnique Fédérale de Lausanne Station 12 Lausanne 1015 Switzerland.

Valeria Cagno (V)

Insitute of Materials École Polytechnique Fédérale de Lausanne Station 12 Lausanne 1015 Switzerland.
Department of Microbiology and Molecular Medicine University of Geneva Rue Michel Servet 1 Geneva 1205 Switzerland.

Paulo Jacob Silva (PJ)

Insitute of Materials École Polytechnique Fédérale de Lausanne Station 12 Lausanne 1015 Switzerland.

Yong Zhu (Y)

Insitute of Materials École Polytechnique Fédérale de Lausanne Station 12 Lausanne 1015 Switzerland.

Laura Sedano (L)

Virologie et Immunologie Moleculaire Institut National Recherche Agronomique Université Paris-Saclay Jouy en Josas 78350 France.

Yoshita Bhide (Y)

Department of Pharmaceutical Technology and Biopharmacy University of Groningen Groningen 9713GZ The Netherlands.
University Medical Center Groningen Department of Medical Microbiology and Infection Prevention (internal postcode EB88) University of Groningen Hanzeplein 1 Groningen 9713GZ The Netherlands.

Joelle Mettier (J)

Virologie et Immunologie Moleculaire Institut National Recherche Agronomique Université Paris-Saclay Jouy en Josas 78350 France.

Chiara Medaglia (C)

Department of Microbiology and Molecular Medicine University of Geneva Rue Michel Servet 1 Geneva 1205 Switzerland.

Bruno Da Costa (B)

Virologie et Immunologie Moleculaire Institut National Recherche Agronomique Université Paris-Saclay Jouy en Josas 78350 France.

Samuel Constant (S)

Epithelix Sas Chemin des Aulx 18 Geneva 1228 Switzerland.

Song Huang (S)

Epithelix Sas Chemin des Aulx 18 Geneva 1228 Switzerland.

Laurent Kaiser (L)

Hopital Universitaire de Genève Rue Gabrielle Perret Gentil 4 Geneva 1205 Switzerland.

Wouter L J Hinrichs (WLJ)

Department of Pharmaceutical Technology and Biopharmacy University of Groningen Groningen 9713GZ The Netherlands.

Anke Huckriede (A)

University Medical Center Groningen Department of Medical Microbiology and Infection Prevention (internal postcode EB88) University of Groningen Hanzeplein 1 Groningen 9713GZ The Netherlands.

Ronan Le Goffic (R)

Virologie et Immunologie Moleculaire Institut National Recherche Agronomique Université Paris-Saclay Jouy en Josas 78350 France.

Caroline Tapparel (C)

Department of Microbiology and Molecular Medicine University of Geneva Rue Michel Servet 1 Geneva 1205 Switzerland.

Francesco Stellacci (F)

Insitute of Materials École Polytechnique Fédérale de Lausanne Station 12 Lausanne 1015 Switzerland.
Bioengineering Institute Ecole Polytechnique Fédérale de Lausanne Station 12 Lausanne 1015 Switzerland.

Classifications MeSH